Takeda Pharmaceutical Co Ltd
(NYSE:TAK)
$
13.02
-0.04 (-0.31%)
Market Cap: 40.86 Bil
Enterprise Value: 68.74 Bil
PE Ratio: 40.31
PB Ratio: 0.88
GF Score: 68/100 Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
May 11, 2022 / 10:00AM GMT
Release Date Price:
$13.93
(-4.06%)
Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance
Presentation
May 11, 2022 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot